Author:
Chen Y. Z.,Xue J. Y.,Chen C. M.,Yang B. L.,Xu Q. H.,Wu F.,Liu F.,Ye X.,Meng X.,Liu G. Y.,Shen Z. Z.,Shao Z. M.,Wu J.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference23 articles.
1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (1998) Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352:930–942
2. Robain M, Pierga JY, Jouve M et al (2000) Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer. Eur J Cancer 362:301–2312
3. Chang J, Clark GM, Allred DC et al (2003) Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer 97:545–553
4. Andre F, Mazouni C, Hortobagyi GN et al (2006) DNA arrays as predictors of efficacy of adjuvant/neoadjuvant chemotherapy in breast cancer patients: current data and issues on study design. Biochim Biophys Acta 1766:197–204
5. Chuthapisith S, Eremin JM, Eremin O (2008) Predicting response to neoadjuvant chemotherapy in breast cancer: molecular imaging, systemic biomarkers and the cancer metabolome (review). Oncol Rep 20:699–703
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献